Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.4% |
| 2 | Technology | 3.32% |
| 3 | Consumer Discretionary | 2.87% |
| 4 | Financials | 2.84% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4251
CALL
Scorpio Tankers
STNG
$3.83B
| $2.17M | ﹤0.01% |
169,100
-319,500
| -65% | -$5.79M |
|
4252
Harmony Gold Mining
HMY
$12.4B
| $2.16M | ﹤0.01% |
518,864
+352,544
| +212% | +$1.16M |
|
|
SIOX
4253
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $2.16M | ﹤0.01% |
767,416
-87,855
| -10% | -$282K |
|
|
KBAL
4254
DELISTED
Kimball International
KBAL
| $2.16M | ﹤0.01% |
187,084
+92,428
| +98% | +$1.06M |
|
|
CLVS
4255
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.16M | ﹤0.01% |
320,300
-89,900
| -22% | -$681K |
|
4256
Medifast
MED
$135M
| $2.16M | ﹤0.01% |
15,576
-21,436
| -58% | -$1.97M |
|
4257
CALL
10x Genomics
TXG
$7.63B
| $2.16M | ﹤0.01% |
24,200
-6,300
| -21% | -$491K |
|
|
XEC
4258
CALL
DELISTED
CIMAREX ENERGY CO
XEC
| $2.16M | ﹤0.01% |
78,600
-10,800
| -12% | -$268K |
|
4259
PUT
Franklin Resources
BEN
$17B
| $2.16M | ﹤0.01% |
103,000
-29,300
| -22% | -$553K |
|
|
VBTX
4260
DELISTED
Veritex Holdings
VBTX
| $2.16M | ﹤0.01% |
122,010
-58,320
| -32% | -$947K |
|
4261
G-III Apparel Group
GIII
$1.48B
| $2.16M | ﹤0.01% |
162,488
-515,201
| -76% | -$5.69M |
|
|
PDM
4262
Piedmont Realty Trust
PDM
$1.16B
| $2.16M | ﹤0.01% |
129,920
-143,768
| -53% | -$2.4M |
|
|
SNBR
4263
CALL
DELISTED
Sleep Number
SNBR
| $2.16M | ﹤0.01% |
51,800
+23,900
| +86% | +$760K |
|
4264
PUT
National Health Investors
NHI
$3.59B
| $2.16M | ﹤0.01% |
35,500
+10,500
| +42% | +$577K |
|
|
BSTC
4265
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $2.15M | ﹤0.01% |
35,176
+5,117
| +17% | +$296K |
|
4266
CALL
Cannae Holdings
CNNE
$644M
| $2.15M | ﹤0.01% |
52,400
+35,800
| +216% | +$1.22M |
|
|
ADAP
4267
PUT
DELISTED
Adaptimmune Therapeutics
ADAP
| $2.15M | ﹤0.01% |
215,100
+188,500
| +709% | +$1.18M |
|
4268
Enanta Pharmaceuticals
ENTA
$402M
| $2.15M | ﹤0.01% |
42,885
-89,608
| -68% | -$4.64M |
|
4269
EMQQ The Emerging Markets Internet & Ecommerce ETF
EMQQ
$275M
| $2.15M | ﹤0.01% |
+46,075
| New | +$1.78M |
|
4270
Magnite
MGNI
$3.47B
| $2.15M | ﹤0.01% |
322,473
-79,301
| -20% | -$495K |
|
4271
ADT
ADT
$5.49B
| $2.15M | ﹤0.01% |
269,381
+255,324
| +1,816% | +$1.65M |
|
4272
CALL
Ashland
ASH
$3.45B
| $2.15M | ﹤0.01% |
31,100
-6,200
| -17% | -$385K |
|
|
CHIX
4273
DELISTED
Global X MSCI China Financials ETF
CHIX
| $2.15M | ﹤0.01% |
155,986
+22,638
| +17% | +$311K |
|
4274
CALL
AMC Entertainment Holdings
AMC
$2.16B
| $2.15M | ﹤0.01% |
50,060
+3,160
| +7% | +$138K |
|
4275
Compañía de Minas Buenaventura
BVN
$8.78B
| $2.15M | ﹤0.01% |
+234,972
| New | +$1.9M |
|
Similar funds
Citadel Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, Citadel Advisors held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Citadel Advisors withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.4% of assets, down from 4% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Citadel Advisors opened a new position in Becton Dickinson worth $266M.
- Citadel Advisors's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Citadel Advisors added most to Amazon in Q2 2020, an estimated $861M increase.
- Citadel Advisors's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Citadel Advisors fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Citadel Advisors's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Citadel Advisors opened 1,506 new positions and closed 1,324 in Q2 2020.
- Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.